Pulmonary Pharmacology

Human C-C chemokine receptor 3 monoclonal antibody inhibits pulmonary inflammation in allergic mice



To evaluate the effect of C-C chemokine receptor 3 (CCR3) blockade on pulmonary inflammation and mucus production in allergic mice.


We used the synthetic peptide of the CCR3 NH2-terminal as the immunizing antigen and generated murine monoclonal antibody against the human CCR3. In addition, the generated antibody was administered to mice sensitized and challenged with ovalbumin. The inflammatory cells in bronchoalveolar lavage, cytokine levels, pulmonary histopathology, and mucus secretion were examined.


The Western blotting analysis indicated that the generated antibody bound to CCR3 specifically. The allergic mice treated with the antihuman CCR3 antibody exhibited a significant reduction of pulmonary inflammation accompanied with the alteration of cytokine.


The antibody we generated was specific to CCR3. The inhibition of airway inflammation and mucus overproduction by the antibody suggested that the blockade of CCR3 is an appealing therapeutical target for asthma. The present research may provide an experimental basis for the further study of this agent.


  1. 1

    O'Byrne P . Asthma pathogenesis and allergen-induced late responses. J Allergy Clin Immunol 1998; 102: S85.

    CAS  Article  Google Scholar 

  2. 2

    Agrawal DK, Bharadwaj A . Allergic airway inflammation. Curr Allergy Asthma Rep 2005; 5: 142–8.

    CAS  Article  Google Scholar 

  3. 3

    Kumar RK, Herbert C, Thomas PS, Wollin L, Beume R, Yang M, et al. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 2003; 307: 349–55.

    CAS  Article  Google Scholar 

  4. 4

    Tomkinson A, Cieslewicz G, Duez C, Larson KA, Lee JJ, Gelfand EW . Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med 2001; 163: 721–30.

    CAS  Article  Google Scholar 

  5. 5

    Luster AD . Chemokines – chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436–45.

    CAS  Article  Google Scholar 

  6. 6

    Mackay CR . Chemokines: immunology's high impact factors. Nat Immunol 2001; 2: 95–101.

    CAS  Article  Google Scholar 

  7. 7

    Garcia G, Godot V, Humbert M . New chemokine targets for asthma therapy. Curr Allergy Asthma Rep 2005; 5: 155–60.

    CAS  Article  Google Scholar 

  8. 8

    Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME . The eotaxin chemokines and CCR3 are fundamental regulators of allergen-inducedpulmonary eosinophilia. J Immunol 2005; 175: 5341–50.

    CAS  Article  Google Scholar 

  9. 9

    Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A, et al. The murine CCR3 receptor regulates both the role of eosino-phils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA 2002; 99: 1479–84.

    CAS  Article  Google Scholar 

  10. 10

    Sallusto F, Mackay CR, Lanzavecchia A . Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005–7.

    CAS  Article  Google Scholar 

  11. 11

    Bisset LR, Schmid-Grendelmeier P . Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med 2005; 11: 35–42.

    CAS  Article  Google Scholar 

  12. 12

    Alvarez D, Wiley RE, Jordana M . Cytokine therapeutics for asthma: an appraisal of current evidence and future prospects. Curr Pharm Des 2001; 7: 1059–81.

    CAS  Article  Google Scholar 

  13. 13

    Zhang L, Soares MP, Guan Y, Matheravidathu S, Wnek R, Johnson KE, et al. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies. J Biol Chem 2002; 277: 33799–810.

    CAS  Article  Google Scholar 

  14. 14

    Bousquet J . Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000; 30 Suppl 1: 2–5.

    Article  Google Scholar 

  15. 15

    Sally EW, Ronina C . Update in asthma 2005. Am J Respir Crit Care Med 2006; 173: 698–706.

    Article  Google Scholar 

  16. 16

    Ichinose M, Barnes PJ . Cytokine-directed therapy in asthma. Curr Drug Targets Inflamm Allergy 2004; 3: 263–9.

    CAS  Article  Google Scholar 

  17. 17

    Das AM, Vaddi KG, Solomon KA, Krauthauser C, Jiang X, McIntyre KW, et al. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation. J Pharmacol Exp Ther 2006; 318: 411–7.

    CAS  Article  Google Scholar 

  18. 18

    Shen HH, Xu F, Zhang GS, Wang SB . CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma. Acta Pharmacol Sin 2006; 27: 1594–9.

    CAS  Article  Google Scholar 

  19. 19

    Zhang GS, Shen HH . The preventive effect of bacillus Calmette-Guerin vaccination in early life on airway inflammation and mucus production in a murine model of asthma. Zhonghua Jie He He Hu Xi Za Zhi 2005; 28: 17–21. Chinese.

    PubMed  Google Scholar 

  20. 20

    Abonyo BO, Alexander MS, Heiman AS . Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005; 289: L478–88.

    CAS  Article  Google Scholar 

  21. 21

    Siegle JS, Hansbro N, Herbert C, Yang M, Foster PS, Kumar RK . Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am J Respir Cell Mol Biol 2006; 35: 565–70.

    CAS  Article  Google Scholar 

  22. 22

    Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997; 99: 178–84.

    CAS  Article  Google Scholar 

  23. 23

    Grimaldi JC, Yu NX, Grunig G, Seymour BW, Cottrez F, Robinson DS, et al. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J Leukoc Biol 1999; 65: 846–53.

    CAS  Article  Google Scholar 

  24. 24

    Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, et al. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J Immunol 1998; 161: 6139–47.

    CAS  PubMed  Google Scholar 

  25. 25

    Steinke JW . Anti-interleukin-4 therapy. Immunol Allergy Clin North Am 2004; 24: 599–614.

    Article  Google Scholar 

  26. 26

    Kelly-Welch AE, Melo ME, Smith E, Ford AQ, Haudenschild C, Norben-Trauth N, et al. Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation. J Immunol 2004; 172: 4545–55.

    CAS  Article  Google Scholar 

  27. 27

    Justice JP, Borchers MT, Crosby JR, Hines EM, Shen HH, Ochkur SI, et al. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am J Physiol Lung Cell Mol Physiol 2003; 284: L169–78.

    CAS  Article  Google Scholar 

  28. 28

    Bandeira-Melo C, Sugiyama K, Woods LJ, Weller PF . Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol 2001; 166: 4813–7.

    CAS  Article  Google Scholar 

  29. 29

    Devouassoux G, Metcalfe DD, Prussin C . Eotaxin potentiates antigen-dependent basophil IL-4 production. J Immunol 1999; 163: 2877–82.

    CAS  PubMed  Google Scholar 

Download references

Author information



Corresponding authors

Correspondence to Kai Wang or Hua-hao Shen.

Additional information

Project supported by the National Natural Science Foundation of China (No 30570807) and the Natural Science Foundation of Zhejiang Province, China (No Z303761).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wang, K., Shen, Hh., Li, W. et al. Human C-C chemokine receptor 3 monoclonal antibody inhibits pulmonary inflammation in allergic mice . Acta Pharmacol Sin 28, 1791–1796 (2007). https://doi.org/10.1111/j.1745-7254.2007.00635.x

Download citation


  • asthma
  • C-C chemokine
  • interleukin-4
  • lungs
  • inflammation

Further reading